Models of sarcoidosis

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 21-25

  Altmann, Daniel M ^a   Boyton, Rosemary J ^b,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT;

AUTOIMMUNITY; CELLULAR IMMUNITY; COMPUTER MODEL; GENETIC POLYMORPHISM; GRANULOMA; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL LUNG DISEASE; KVEIM TEST; LUNG SARCOIDOSIS; MICROBIAL IMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SARCOIDOSIS; TH1 CELL; WESTERN HEMISPHERE;

EID: 33645914807     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.018     Document Type: Review

References (33)

1. Baughman R.P., et al. Sarcoidosis. Lancet 361 (2003) 1111-1118
2. Newman L.S., et al. Sarcoidosis. N. Engl. J. Med. 336 (1997) 1224-1233
3. Moller D.R., and Chen E.S. What causes sarcoidosis?. Curr. Opin. Pulm. Med. 8 (2002) 429-434
4. Bergeron A., et al. Cytokine patterns in tuberculous and sarcoid granulomas. Correlations with histopathologic features of the granulomatous response. J. Immunol. 159 (1997) 3034-3043
5. Newman L.S., et al. A case control etiologic study of sarcoidosis. Environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 170 (2004) 1324-1330
6. Rossman M.D., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73 (2003) 720-735
7. Rybicki B.A., et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am. J. Respir. Crit. Care Med. 167 (2003) 444-449
8. Iannuzzi M.C., et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med. 167 (2003) 1225-1231
9. Valentonyte R., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37 (2005) 357-364
10. Song Z., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201 (2005) 755-767
11. Moller D.R. Treatment of sarcoidosis - from a basic science point of view. J. Intern. Med. 253 (2003) 31-40
12. Agostini C., et al. T lymphocytes and cytokines in sarcoidosis. Curr. Opin. Pulm. Med. 8 (2002) 435-440
13. Sharma O. Sarcoidosis and other autoimmune disorders. Curr. Opin. Pulm. Med. 8 (2002) 452-456
14. Grunewald J.C., et al. Restricted Vα2.3 gene usage by CD4+ T lymphocytes in broncheoalveolar lavage fluid from sarcoidosis patients correlated with HLA-DR3. Eur. J. Immunol. 22 (1992) 129-135
15. Zissel G., et al. TCR Vβ families in T cell clones from sarcoid lung parenchyma, BAL and blood. Am. J. Respir. Crit. Care Med. 156 (1997) 1593-1600
16. Ho L.-P., et al. Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis. Lancet 365 (2005) 1062-1072
17. Miyare M., et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203 (2006) 359-370
18. O'Callaghan C.A., et al. Effective use of cyclosporine in sarcoidosis: a treatment strategy based on computed tomography scanning. Eur. Respir. J. 7 (1994) 2255-2256
19. Morris D.G., et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 124 (2003) 929-935
20. Tsiligianni I., et al. Th1/Th1 cytokine pattern in broncheoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm. Med. 5 (2005) 8
21. Katchar K., et al. Characterisation of natural killer cells and CD56+ T cells in sarcoidosis patients. Eur. Respir. J. 26 (2005) 77-85
22. du Bois R.M., et al. Moratorium on Kveim test. Lancet 342 (1993) 173
23. Mitchell D.N., et al. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 2 (1976) 761-765
24. Belcher R.W., and Reid J.D. Sarcoid granulomas in CBA/J mice. Histologic responses after inoculation with sarcoid and nonsarcoid tissue homogenates. Arch. Pathol. 99 (1975) 283-285
25. Iwai K., and Takahashi S. Transmissibility of sarcoid specific granulomas in the footpads of mice. Ann. N. Y. Acad. Sci. 278 (1976) 249-259
26. Grizzanti J.N., and Rosenstreich D.L. Effects of inoculation of sarcoid tissue into athymic (nude) mice. Sarcoidosis 5 (1988) 136-141
27. Soler P., et al. Ultrastructure of pulmonary granulomatosis induced in rats by intravenous complete Freund's adjuvant. Virchows. Arch. A Path. Anat. Histol. 368 (1975) 35-50
28. Bergeron A., et al. Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats. Eur. Respir. J. 18 (2001) 357-361
29. Nishiwaki T., et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am. J. Pathol. 165 (2004) 631
30. Co D.O., et al. T cell contribution to the different phases of granuloma formation. Immunol. Lett. 92 (2004) 135-142
31. Layland L.E., et al. Lack of antigen specific Th1 response alters granuloma formation and composition in Schistosome mansoni-infected MyD88 -/- mice. Eur J. Immunol. 35 (2005) 3248-3257
32. Iizasa H., et al. Exacerbation of granuloma formation in IL-1 receptor antagonist deficient mice with impaired dendritic cell maturation associated with Th2 cytokine production. J. Immunol. 174 (2005) 3273-3280
33. Freeman C.M., et al. CCR8 is expressed by antigen-elicited, IL-10 producing CD4+CD25+ T cells which regulate Th2-mediated granuloma formation in mice. J. Immunol. 174 (2005) 1962-1970